[ Vineti raises $13.75M in Series A ]

Vineti has raised $13.75 million in Series A funding.

Founded in 2016, Vineti  is an intelligent analytics platform that provides personalised cell and gene therapeutics development and delivery solutions.

The new financing will be used to grow its team and to deliver the first cloud-based software solution to improve patient access, accelerate life-saving treatment delivery, and promote safety and regulatory compliance for individualized cell therapies.

Funding  Series A
Founded  2016
Country  USA
City  San Francisco, California
Founder / CEO  Amy DuRoss
Deal Size  $13.75M
Investors  DFJ
 GE Ventures
 Mayo Clinic Ventures
 LifeForce Capital
Previous Investors  /